(0.06%) 5 476.55 points
(0.05%) 38 796 points
(0.04%) 17 865 points
(0.29%) $80.56
(0.82%) $2.81
(0.12%) $2 331.80
(-0.36%) $29.29
(-0.10%) $969.90
(0.03%) $0.932
(-0.14%) $10.64
(0.06%) $0.788
(-1.87%) $86.80
Live Chart Being Loaded With Signals
Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States...
Stats | |
---|---|
Šios dienos apimtis | 5 622 |
Vidutinė apimtis | 18 020 |
Rinkos kapitalizacija | 5.53M |
EPS | $-0.210 ( Q4 | 2023-12-31 ) |
Kita pelno data | ( $0 ) 2024-08-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.870 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-10 | Exploration Capital, Llc | Buy | 86 185 | Common Stock |
2024-06-07 | Exploration Capital, Llc | Buy | 319 315 | Common Stock |
2024-05-31 | Exploration Capital, Llc | Buy | 516 | Common Stock |
2024-05-30 | Exploration Capital, Llc | Buy | 9 838 | Common Stock |
2024-05-29 | Exploration Capital, Llc | Buy | 80 | Common Stock |
INSIDER POWER |
---|
78.66 |
Last 69 transactions |
Buy: 1 307 662 | Sell: 203 920 |
Fresh Tracks Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Fresh Tracks Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $8.01M |
Bruto pelnas: | $8.01M (100.00 %) |
EPS: | $-0.960 |
FY | 2023 |
Pajamos: | $8.01M |
Bruto pelnas: | $8.01M (100.00 %) |
EPS: | $-0.960 |
FY | 2022 |
Pajamos: | $6.94M |
Bruto pelnas: | $-7.10M (-102.26 %) |
EPS: | $-7.36 |
FY | 2021 |
Pajamos: | $404 000 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-22.05 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Fresh Tracks
Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was formerly known as Brickell Biotech, Inc. and changed its name to Fresh Tracks Therapeutics, Inc. in September 2022. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.